The global sports medicine market is anticipated to grow at a compound annual growth rate of 8.9 percent through 2024, according to a Data Bridge Market Research report.
Here are five observations:
1. The market will likely hit $34.7 billion by 2024, up from $16.6 billion in 2016.
2. The rising number of sports injuries and growing adoption of arthroscopic surgeries are spurring market growth.
3. Demand for bone graft substitutes, surgical devices and arthroscopy devices is growing in the market.
4. In 2016, Arthrex accounted for the greatest market share, with Smith & Nephew, DePuy Synthes, Stryker and CONMED following close behind.
5. Johnson & Johnson, Bird & Cronin, Zimmer Biomet, Anika Therapeutics, Ossur, Breg, Mueller Sports Medicine, DJO Global and Medtronic are also key market players.